AMGEN INC (AMGN) Options Risk Score

Run a full AMGN options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on AMGEN INC (AMGN) right now?

AMGEN INC (AMGN) currently scores 41 out of 100 for options catalyst risk (LOW) over a 4-week expiry window. That score is driven by 4 recent news items, 10 active legal filings and 16 clinical-trial catalysts falling inside the 4-week window. A LOW score (under 45) means the scan found no dated catalyst for AMGN inside the window. Read it as a clean calendar rather than a safe stock — surprises are by definition unscheduled.

AMGN shows an IV Rank of 54, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 33%. IV Rank is the most useful figure for deciding whether to sell or buy premium on AMGN.

The next AMGN report is not until 2026-11-03, beyond the near-term window.

AMGEN INC (AMGN) current implied volatility and IV Rank

As of the latest scan, AMGEN INC (AMGN) shows an IV Rank of 54 with implied volatility around 33%, alongside a TickerRisk options-risk score of 41/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

For what this number does and does not tell you about AMGN's options, see IV Rank explained.

AMGEN INC (AMGN) next earnings date — 2026-11-03

The next report for AMGN is 2026-11-03 — about 13 days away, which sits beyond the nearest expiry. Nothing scheduled is threatening a near-dated position today, though premium on longer expiries will start to reflect the date as it approaches. AMGN's IV Rank is currently 54.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer